ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
13.30
-0.71 (-5.07%)
Jul 16, 2026, 4:00 PM EDT - Market closed
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $119.27 million as of July 16, 2026. Its market cap has increased by 729.24% in one year.
Market Cap
119.27M
Enterprise Value
55.42M
1-Year Change
729.24%
Ranking
Category
Stock Price
$13.30
ChartMarket Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $119.27M, an increase of 446.57%. That is a compound annual growth rate of 12.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 119.27M | 711.90% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genelux | 129.90M |
| Fractyl Health | 127.14M |
| enGene Therapeutics | 126.28M |
| Cue Biopharma | 125.21M |
| Vivani Medical | 123.32M |
| Seer, Inc. | 118.76M |
| Aldeyra Therapeutics | 117.93M |
| Fortress Biotech | 114.94M |